VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
LVMH Moet Hennessy Louis Vuitton SE vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
LVMH Moet Hennessy Louis Vuitton SE
MC · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into LVMH Moet Hennessy Louis Vuitton SE's moat claims, evidence, and risks.
View MC analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: LVMH Moet Hennessy Louis Vuitton SE leads (80 / 100 vs 74 / 100 for Sanofi).
- Segment focus: LVMH Moet Hennessy Louis Vuitton SE has 5 segments (48.5% in Fashion and Leather Goods); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: LVMH Moet Hennessy Louis Vuitton SE has 9 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
LVMH Moet Hennessy Louis Vuitton SE
Fashion and Leather Goods
Luxury fashion and leather goods
Global
Consumers via directly operated retail; selective wholesale
Brand owner / design house / manufacturer / retailer
48.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
LVMH Moet Hennessy Louis Vuitton SE strengths
Sanofi strengths
Segment mix
LVMH Moet Hennessy Louis Vuitton SE segments
Full profile >Fashion and Leather Goods
Oligopoly
Wines and Spirits
Oligopoly
Perfumes and Cosmetics
Oligopoly
Watches and Jewelry
Oligopoly
Selective Retailing
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.